BIOVENTUS INC. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/73b99f0b-1b1a-4eeb-b291-b78a26303891/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $568.1M | 2025-01-01 – 2025-12-31 | evidence 0001665988-26-000011 |
| FY 2024 | $573.3M | 2024-01-01 – 2024-12-31 | evidence 0001628280-25-011831 |
| FY 2023 | $512.3M | 2023-01-01 – 2023-12-31 | evidence 0001628280-24-010376 |
| FY 2022 | $512.1M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-010151 |
| FY 2021 | $430.9M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-005816 |
| FY 2020 | $321.2M | 2020-01-01 – 2020-12-31 | evidence 0001628280-22-005816 |
| FY 2019 | $340.1M | 2019-01-01 – 2019-12-31 | evidence 0001628280-22-005816 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).